References
- Effer SB, Moutquin JM, Farine D, Saigal S, Nimrod C, Kelly E, et al. Neonatal survival rates in 860 singleton live births at 24 and 25 weeks gestational age. A Canadian multicentre study. BJOG 2002;109:740- 5. https://doi.org/10.1111/j.1471-0528.2002.01067.x
- El-Metwally D, Vohr B, Tucker R. Survival and neonatal morbidity at the limits of viability in the mid 1990s: 22 to 25 weeks. J Pediatr 2000;137:616-22. https://doi.org/10.1067/mpd.2000.109143
- La Pine TR, Jackson JC, Bennett FC. Outcome of infants weighing less than 800 grams at birth: 15 years' experience. Pediatrics 1995; 96:479-83.
- Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26-30.
- Gray PH, Burns YR, Mohay HA, O'Callaghan MJ, Tudehope DI. Neurodevelopmental outcome of preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995;73: F128-34. https://doi.org/10.1136/fn.73.3.F128
- Danhaive O, Margossian R, Geva T, Kourembanas S. Pulmonary hypertension and right ventricular dysfunction in growth-restricted, extremely low birth weight neonates. J Perinatol 2005;25:495-9. https://doi.org/10.1038/sj.jp.7211299
- Gorenflo M, Vogel M, Obladen M. Pulmonary vascular changes in bronchopulmonary dysplasia: a clinicopathologic correlation in short- and long-term survivors. Pediatr Pathol 1991;11:851-66. https://doi.org/10.3109/15513819109065482
- Hislop AA, Haworth SG. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990;9:152-61. https://doi.org/10.1002/ppul.1950090306
- Kasian GF, Ninan A, Duncan WJ, Bingham WT, Mersal A, Tyrrell MJ, et al. Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia. Can J Cardiol 1988;4:181- 4.
- Parker TA, Abman SH. The pulmonary circulation in bronchopulmonary dysplasia. Semin Neonatol 2003;8:51-61. https://doi.org/10.1016/S1084-2756(02)00191-4
- Farquhar M, Fitzgerald DA. Pulmonary hypertension in chronic neonatal lung disease. Paediatr Respir Rev 2010;11:149-53. https://doi.org/10.1016/j.prrv.2010.05.001
- Kumar VH, Hutchison AA, Lakshminrusimha S, Morin FC, 3rd, Wynn RJ, Ryan RM. Characteristics of pulmonary hypertension in preterm neonates. J Perinatol 2007;27:214-9.
- Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007;120:1260-9. https://doi.org/10.1542/peds.2007-0971
- An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 2010;40:131-6. https://doi.org/10.4070/kcj.2010.40.3.131
- Dhillon R. The management of neonatal pulmonary hypertension. Arch Dis Child Fetal Neonatal Ed. In press 2011.
- Hon KL, Cheung KL, Siu KL, Leung TF, Yam MC, Fok TF, et al. Oral sildenafil for treatment of severe pulmonary hypertension in an infant. Biol Neonate 2005;88:109-12. https://doi.org/10.1159/000085646
- Tourneux P, Markham N, Seedorf G, Balasubramaniam V, Abman SH. Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats. Am J Physiol Lung Cell Mol Physiol 2009;297:L1103-11. https://doi.org/10.1152/ajplung.00293.2009
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9. https://doi.org/10.1164/ajrccm.163.7.2011060
- Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006;117:S52-6.
- Srivastava MC, Ramani GV, Garcia JP, Griffith BP, Uber PA, Park MH. Veno-venous extracorporeal membrane oxygenation bridging to pharmacotherapy in pulmonary arterial hypertensive crisis. J Heart Lung Transplant 2010;29:811-3. https://doi.org/10.1016/j.healun.2010.02.005
- Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34. https://doi.org/10.1016/S0022-3476(78)80282-0
- Maalouf EF, Duggan PJ, Counsell SJ, Rutherford MA, Cowan F, Azzopardi D, et al. Comparison of findings on cranial ultrasound and magnetic resonance imaging in preterm infants. Pediatrics 2001;107:719-27. https://doi.org/10.1542/peds.107.4.719
- Wadhawan R, Oh W, Perritt R, Laptook AR, Poole K, Wright LL, et al. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birthweight infants. J Perinatol 2007;27:359-64. https://doi.org/10.1038/sj.jp.7211751
- Westby Wold SH, Sommerfelt K, Reigstad H, Ronnestad A, Medbo S, Farstad T, et al. Neonatal mortality and morbidity in extremely preterm small for gestational age infants: a population based study. Arch Dis Child Fetal Neonatal Ed 2009;94:F363-7. https://doi.org/10.1136/adc.2009.157800
- Kim GB. Pulmonary hypertension in infants with bronchopulmonary dysplasia. Korean J Pediatr 2010;53:688-93. https://doi.org/10.3345/kjp.2010.53.6.688
- Zellers T, Gutgesell HP. Noninvasive estimation of pulmonary artery pressure. J Pediatr 1989;114:735-41. https://doi.org/10.1016/S0022-3476(89)80129-5
- Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984;70:657-62. https://doi.org/10.1161/01.CIR.70.4.657
- Subhedar NV. Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease. Acta Paediatr Suppl 2004;93:29-32.
- Bentlin MR, Saito A, De Luca AK, Bossolan G, Bonatto RC, Martins AS, et al. [Sildenafil for pulmonary hypertension treatment after cardiac surgery]. J Pediatr (Rio J) 2005;81:175-8.
- Hoeper MM, Galiè N, Simonneau G, Rubin LJ. New treatments for pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165:1209-16. https://doi.org/10.1164/rccm.200110-028PP
- Lee AJ, Chiao TB, Tsang MP. Sildenafil for pulmonary hypertension. Ann Pharmacother 2005;39:869-84. https://doi.org/10.1345/aph.1E426
- Zaidi AN, Dettorre MD, Ceneviva GD, Thomas NJ. Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease. Pediatr Pulmonol 2005;40: 265-9. https://doi.org/10.1002/ppul.20238
- Atz AM, Wessel DL. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999;91:307-10. https://doi.org/10.1097/00000542-199907000-00041
- Chatterjee K, De Marco T, Alpert JS. Pulmonary hypertension: hemodynamic diagnosis and management. Arch Intern Med 2002;1 62:1925-33.
- Murase M, Ishida A. Serial pulsed Doppler assessment of pulmonary artery pressure in very low birth-weight infants. Pediatr Cardiol 2000;21:452-7. https://doi.org/10.1007/s002460010107
- Solis A, Harrison G, Shaw BN. Assessing oxygen requirement after discharge in chronic lung disease: a survey of current practice. Eur J Pediatr 2002;161:428-30. https://doi.org/10.1007/s00431-002-0991-z
- Abman SH, Accurso FJ, Bowman CM. Unsuspected cardiopulmonary abnormalities complicating bronchopulmonary dysplasia. Arch Dis Child 1984;59:966-70. https://doi.org/10.1136/adc.59.10.966
- Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 2002;87:F15-8. https://doi.org/10.1136/fn.87.1.F15
Cited by
- Strategies to Overcome the Limit of Viability of Microprimie vol.20, pp.3, 2013, https://doi.org/10.5385/nm.2013.20.3.258
- Pathophysiology and Risk Factors of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia vol.25, pp.1, 2011, https://doi.org/10.14734/kjp.2014.25.1.1
- Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants vol.11, pp.1, 2021, https://doi.org/10.1038/s41598-021-90769-4